X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA IPCA LABS ELDER PHARMA/
IPCA LABS
 
P/E (TTM) x -0.2 28.0 - View Chart
P/BV x 0.1 2.1 4.7% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 ELDER PHARMA   IPCA LABS
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
IPCA LABS
Mar-17
ELDER PHARMA/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs380643 59.1%   
Low Rs188503 37.4%   
Sales per share (Unadj.) Rs491.2254.4 193.1%  
Earnings per share (Unadj.) Rs-3.216.1 -19.8%  
Cash flow per share (Unadj.) Rs14.429.8 48.4%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs376.5194.6 193.5%  
Shares outstanding (eoy) m20.54126.20 16.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.62.3 25.7%   
Avg P/E ratio x-89.335.7 -250.4%  
P/CF ratio (eoy) x19.719.2 102.4%  
Price / Book Value ratio x0.82.9 25.6%  
Dividend payout %06.2 0.0%   
Avg Mkt Cap Rs m5,83372,300 8.1%   
No. of employees `000NA13.3 0.0%   
Total wages/salary Rs m2,1796,960 31.3%   
Avg. sales/employee Rs ThNM2,413.5-  
Avg. wages/employee Rs ThNM523.2-  
Avg. net profit/employee Rs ThNM152.4-  
INCOME DATA
Net Sales Rs m10,08932,106 31.4%  
Other income Rs m257226 113.7%   
Total revenues Rs m10,34632,332 32.0%   
Gross profit Rs m-7924,448 -17.8%  
Depreciation Rs m3611,730 20.9%   
Interest Rs m2,756241 1,144.6%   
Profit before tax Rs m-3,6532,703 -135.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125675 18.5%   
Profit after tax Rs m-652,028 -3.2%  
Gross profit margin %-7.813.9 -56.7%  
Effective tax rate %-3.425.0 -13.7%   
Net profit margin %-0.66.3 -10.3%  
BALANCE SHEET DATA
Current assets Rs m9,24017,340 53.3%   
Current liabilities Rs m9,9989,559 104.6%   
Net working cap to sales %-7.524.2 -31.0%  
Current ratio x0.91.8 51.0%  
Inventory Days Days46100 46.2%  
Debtors Days Days6057 105.4%  
Net fixed assets Rs m10,12420,779 48.7%   
Share capital Rs m206252 81.5%   
"Free" reserves Rs m5,58224,499 22.8%   
Net worth Rs m7,73424,553 31.5%   
Long term debt Rs m4,8893,517 139.0%   
Total assets Rs m22,88239,595 57.8%  
Interest coverage x-0.312.2 -2.7%   
Debt to equity ratio x0.60.1 441.3%  
Sales to assets ratio x0.40.8 54.4%   
Return on assets %11.85.7 205.2%  
Return on equity %-0.88.3 -10.2%  
Return on capital %22.310.5 212.7%  
Exports to sales %3.048.6 6.2%   
Imports to sales %0.414.2 3.0%   
Exports (fob) Rs m30715,617 2.0%   
Imports (cif) Rs m434,571 0.9%   
Fx inflow Rs m30715,617 2.0%   
Fx outflow Rs m1255,828 2.2%   
Net fx Rs m1819,790 1.9%   
CASH FLOW
From Operations Rs m11,7542,764 425.2%  
From Investments Rs m-561-1,432 39.1%  
From Financial Activity Rs m-6,762-1,591 424.9%  
Net Cashflow Rs m4,432-259 -1,712.4%  

Share Holding

Indian Promoters % 39.6 45.9 86.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 11.4 65.8%  
FIIs % 16.8 25.3 66.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 17.4 207.5%  
Shareholders   16,479 36,892 44.7%  
Pledged promoter(s) holding % 77.6 2.1 3,624.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   DISHMAN PHARMA  CADILA HEALTHCARE  SUVEN LIFE  PANACEA BIOTECH  WOCKHARDT LTD.  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - BIOCON LTD COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS